Inovio Pharma (NQ: INO )

11.10 USD -0.39 (-3.39%)

Official Closing Price Updated: 7:59 PM EST, Feb 26, 2021 Add to My Watchlist

Price and Volume

Volume	12,264,301
Open	11.56
Bid (Size)	11.36 (25)
Ask (Size)	11.37 (1)
Prev. Close	11.49
Today's Range	10.85 - 11.85
52wk Range	3.830 - 33.79
Shares Outstanding	90,962,081
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies

February 24, 2021

Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies

February 24, 2021

FN Media Group Presents USA News Group News Commentary

Performance

YTD	+14.08%	+14.08%
1 Month	+1.37%	+1.37%
3 Month	-9.17%	-9.17%
6 Month	-7.42%	-7.42%
1 Year	+159.35%	+159.35%

More News

INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia

February 24, 2021

INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa

February 23, 2021

QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO’s VGX-3100 for Advanced Cervical Dysplasia

February 24, 2021

INOVIO to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021

February 16, 2021

Earnings Outlook For Inovio Pharmaceuticals

February 26, 2021

Use This Rally to Ditch QuantumScape Stock, Not to Get Trapped By It

February 25, 2021

Qiagen, Inovio In Development Pact For VGX-3100 Companion Diagnostics

February 24, 2021

INOVIO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inovio Pharmaceuticals Inc. - INO

February 26, 2021

First Week of INO April 16th Options Trading

February 23, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.